Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 29 n° 341

Toshiba Medical Represents Attractive Investment in Diagnostic Imaging Market, says GlobalData Analyst

Posted by fidest press agency su venerdì, 26 febbraio 2016

londonLONDON, UK (GlobalData) Investing in Toshiba Medical, which is seeking potential partners, is likely to deliver strong returns for companies looking to expand into the diagnostic imaging space, particularly in the Japanese market, according to an analyst with research and consulting firm GlobalData.Thanks to a growing population with a steady demand for non-invasive diagnostic procedures, imaging devices have remained a lucrative investment and GlobalData forecasts that the global diagnostic imaging market will be valued at $42.4 billion by 2020.As Sarah Janer, GlobalData’s Analyst covering Medical Devices, explains: “Toshiba Medical is a steady performer and its sales make up 10% of the thriving global market, which is tempting for companies looking to break into diagnostic imaging.
“Japanese firms are especially interested, as Toshiba Medical possesses 19.2% of the diagnostic imaging market in Japan. Canon Inc. and Fujifilm are stepping up to bid, and while both offer digital radiography devices, heavy investment in Toshiba Medical could expand their range to computed tomography (CT) and magnetic resonance imaging (MRI) systems.” GlobalData estimates that the current markets for CT and MRI devices are expanding at compound annual growth rates of 14.3% and 10.4%, respectively.Janer notes: “Investment opportunities are so attractive that Toshiba’s CEO Masashi Muromachi has hinted at already receiving opening bids significantly higher than the reported asking price of $3 billion for an 80% share. Canon and Fujifilm have partnered with other firms to improve the strength of their bid, demonstrating a strong eagerness to invest.“Certainly, as both companies have less than a 3% share of the global diagnostic imaging market, a buyout could significantly boost their chances of competing with imaging titans like Siemens or GE Healthcare.”
Although Toshiba ranks fourth for global market share, collaboration could lead to innovation and some fierce competition down the road, depending on what percentage of Toshiba Medical is sold off.Janer continues: “A 51% percent company share could result in some collaboration, but Toshiba’s restructuring plans would need to succeed. Full investment would result in a more stable outlook and a market share increase of up to 20% for the successful buyer, according to GlobalData.”

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione / Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione / Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione / Modifica )

Google+ photo

Stai commentando usando il tuo account Google+. Chiudi sessione / Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: